Quince Therapeutics, Inc. (QNCX)
Quince Therapeutics, Inc., a biopharmaceutical company, focuses on advancing precision therapeutics for debilitating and rare diseases. The company has discovered a broad bone-targeting drug platform to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease. Its lead compound is NOV004, an anabolic peptide engineered to precisely target and concentrate at the bone fracture site The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. Quince Therapeutics, Inc. was incorporated in 2012 and is headquartered in South San Francisco, California.
$37.45M
Dr. Dirk Thye M.D.
55.00
South San Francisco, CA
-
-0.69
$-1.26
11.60
45.36
0.00%
-1.00
0.36
0.00
44.86
-35.10%
-32.63%
Similar stocks (11)
Revolution Medicines, Inc.
RVMD
Edgewise Therapeutics, Inc.
EWTX
Nuvation Bio Inc.
NUVB
Third Harmonic Bio, Inc.
THRD
Instil Bio, Inc.
TIL
PepGen Inc.
PEPG
Assembly Biosciences, Inc.
ASMB
Ovid Therapeutics Inc.
OVID
PMV Pharmaceuticals, Inc.
PMVP
NextCure, Inc.
NXTC
AN2 Therapeutics, Inc.
ANTX
Similar stocks (11)
Revolution Medicines, Inc.
RVMD
Edgewise Therapeutics, Inc.
EWTX
Nuvation Bio Inc.
NUVB
Third Harmonic Bio, Inc.
THRD
Instil Bio, Inc.
TIL
PepGen Inc.
PEPG
Assembly Biosciences, Inc.
ASMB
Ovid Therapeutics Inc.
OVID
PMV Pharmaceuticals, Inc.
PMVP
NextCure, Inc.
NXTC
AN2 Therapeutics, Inc.
ANTX